ACCG-2671
First-in-human Study of the Safety, Tolerability, Pharmacokinetics, and Food Effect of ACCG-2671
Aconcagua Bio, Inc · Phase 1/2 · Recruiting · Enrollment 164
No selected arm has a reported week for this endpoint.
A solid line connects the weeks the source reports.